Barry J. Cusack
Impact in
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiac electrophysiology and arrhythmias
Papers in
- Biophysics 10
- Electron Spin Resonance Studies 9
-
- Chemotherapy-induced cardiotoxicity and mitigation 21
- Co-authors
- Richard D. OlsonRobert E. VestalRobert J. BoucekPhillip S. MushlinSidney FleischerCho‐Ming LoiBaojun ChangDean E. Brenner
- Journals
- Cancer Chemotherapy and Pharmacology (6 papers)Cardiovascular Toxicology (4 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)Clinical Pharmacology & Therapeutics (3 papers)British Journal of Pharmacology (3 papers)
- Partner nations
- United StatesSri LankaJapan
In The Last Decade
Barry J. Cusack
44 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 124
- Geriatrics and Gerontology 217
- Cardiology and Cardiovascular Medicine 822
- Biophysics 191
- Pharmacology 284
- Oncology 528
Countries citing papers authored by Barry J. Cusack
This map shows the geographic impact of Barry J. Cusack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry J. Cusack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry J. Cusack more than expected).
Fields of papers citing papers by Barry J. Cusack
This network shows the impact of papers produced by Barry J. Cusack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry J. Cusack. The network helps show where Barry J. Cusack may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Barry J. Cusack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 16 | |
| 2 | 2005 | 51 | |
| 3 | 2005 | 20 | |
| 4 | 2003 | 15 | |
| 5 | 2002 | 16 | |
| 6 | 2002 | 33 | |
| 7 | 2002 | 5 | |
| 8 | 2002 | 9 | |
| 9 | 2000 | 58 | |
| 10 | 2000 | 18 | |
| 11 | 1997 | 7 | |
| 12 | 1995 | 18 | |
| 13 | 1993 | 45 | |
| 14 | 1993 | 64 | |
| 15 | 1993 | 10 | |
| 16 | 1990 | 152 | |
| 17 | 1990 | 47 | |
| 18 | 1989 | 291 | |
| 19 | 1988 | 19 | |
| 20 | 1987 | 21 |
About Barry J. Cusack
Barry J. Cusack is a scholar working on Biophysics, Cardiology and Cardiovascular Medicine, Pharmacology, Geriatrics and Gerontology and Oncology, having authored 44 papers that have together received 2.0k indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (21 papers), Cancer Treatment and Pharmacology (13 papers), Electron Spin Resonance Studies (9 papers), Pharmacogenetics and Drug Metabolism (7 papers), Pharmaceutical studies and practices (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), Analytical Methods in Pharmaceuticals (4 papers) and Chemotherapy-related skin toxicity (3 papers). The work is most often cited by research in Geriatrics and Gerontology (217 citations), Cardiology and Cardiovascular Medicine (822 citations), Biophysics (191 citations), Pharmacology (284 citations) and Oncology (528 citations). Barry J. Cusack has collaborated with scholars based in United States, Sri Lanka and Japan. Frequent co-authors include Richard D. Olson, Robert E. Vestal, Robert J. Boucek, Phillip S. Mushlin, Sidney Fleischer, Cho‐Ming Loi, Baojun Chang, Dean E. Brenner, Joseph J. Crowley and Hervé A. Gambliel. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Cardiovascular Toxicology, Journal of Pharmacology and Experimental Therapeutics, Clinical Pharmacology & Therapeutics and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.